Merida Biosciences

Merida Biosciences is a biotechnology company developing a new class of precision therapeutics to eliminate pathogenic antibody drivers in autoimmune and allergic diseases. Their novel platform targets specific antibodies, offering durable depletion without broad immunosuppression. The company has programs targeting Graves’ disease, allergy, and primary membranous nephropathy.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $121M

Date: 08-Apr-2025

Investors: Bain Capital Life Sciences, BVF Partners, Third Rock Ventures, GV, Perceptive Xontogeny Venture Funds (PXV Funds)

Markets: Biotechnology, Therapeutics, Autoimmune Diseases, Allergic Diseases

HQ: Cambridge, Massachusetts, United States

Founded: 2022

Website: https://www.meridabio.com

LinkedIn: https://www.linkedin.com/company/merida-biosciences

Twitter:

Instagram: